EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection

Lili Wang iD, Paul N Patrone, Anthony J Kearsley, Jerilyn R Izac iD, Adolfas K Gaigalas, John C Prostko, Hyung Joon Kwon, Weichun Tang, Martina Kosikova, Hang Xie iD, Linhua Tian iD, Elzafir B Elsheikh und 7 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lili Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 has highlighted challenges in the measurement quality and comparability of serological binding and neutralization assays. Due to many different assay formats and reagents, these measurements are known to be highly variable with large uncertainties. The development of the WHO international standard (WHO IS) and other pool standards have facilitated assay comparability through normalization to a common material but does not provide assay harmonization nor uncertainty quantification. In this paper, we present the results from an interlaboratory study that led to the development of (1) a novel hierarchy of data analyses based on the thermodynamics of antibody binding and (2) a modeling framework that quantifies the probability of neutralization potential for a given binding measurement. Importantly, we introduced a precise, mathematical definition of harmonization that separates the sources of quantitative uncertainties, some of which can be corrected to enable, for the first time, assay comparability. Both the theory and experimental data confirmed that mAbs and WHO IS performed identically as a primary standard for establishing traceability and bridging across different assay platforms. The metrological anchoring of complex serological binding and neuralization assays and fast turn-around production of an mAb reference control can enable the unprecedented comparability and traceability of serological binding assay results for new variants of SARS-CoV-2 and immune responses to other viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansAntibodies, MonoclonalBiological AssayData AnalysisAntibodies, ViralAntibodies, Neutralizing

Stichwörter der Autor:innen

SARS-CoV-2WHO international standard (WHO IS)harmonizationmonoclonal antibodyneutralization assaynormalizationresult comparability and traceabilityserological binding assayspike proteinuncertainty quantification

Substanzen

Antibodies, MonoclonalAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
  • Applied and Computational Mathematics Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD 20899, USA.
  • Abbott Laboratories, Abbott Park, IL 60064, USA.
  • Laboratory of Pediatric and Respiratory Viral Diseases, Office of Vaccines Research and Review, Center for Biologics Evaluation, Food and Drug Administration (FDA), Silver Spring, MD 20993, USA.
  • Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21702, USA.
  • Roche Diagnostics GmbH, 82377 Penzberg, Germany.

ORCID-Profile: Lili Wang, Jerilyn R Izac, Hang Xie, Linhua Tian, Edward J Kwee, Natalie Thornburg, L Clifford McDonald

Zitieren

APA

Wang, L., Patrone, P. N., Kearsley, A. J., Izac, J. R., Gaigalas, A. K., Prostko, J. C., Kwon, H. J., Tang, W., Kosikova, M., Xie, H., Tian, L., Elsheikh, E. B., Kwee, E. J., Kemp, T., Jochum, S., Thornburg, N., McDonald, L. C., Gundlapalli, A. V., & Lin-Gibson, S. (2023). Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115705

Vancouver

Wang L, Patrone PN, Kearsley AJ, Izac JR, Gaigalas AK, Prostko JC, et al. Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115705

BibTeX
@article{Wang2023,
  author = {Wang, Lili and Patrone, Paul N and Kearsley, Anthony J and Izac, Jerilyn R and Gaigalas, Adolfas K and Prostko, John C and Kwon, Hyung Joon and Tang, Weichun and Kosikova, Martina and Xie, Hang and Tian, Linhua and Elsheikh, Elzafir B and Kwee, Edward J and Kemp, Troy and Jochum, Simon and Thornburg, Natalie and McDonald, L Clifford and Gundlapalli, Adi V and Lin-Gibson, Sheng},
  title = {Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115705}
}
Kostenlos starten →